Puma Biotechnology Competitors and Similar CompaniesClear all

Puma Biotechnology's competitors and similar companies include Oncopeptides.
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
Oncopeptides
Oncopeptides
Oncopeptides is a clinical development pharmaceutical company.
Founding Date
Founding Date
2010
Founding Date
2000
Type
Type
Public
Type
Public
Tags
Locations
Locations
Los Angeles, US HQ
Locations
Stockholm, SE HQ
Stockholm, SE
Los Altos, US
Mountain View, US
Waltham, US
Employees
Employees
27214% decrease
Employees
80
Valuation ($)
Valuation ($)
136.8 m
Valuation ($)
42.4 m

Financial

Revenue (est.)
Revenue (est.)
$228.4m (FY, 2025)
Revenue (est.)
kr71.1m (FY, 2025)
Cost of goods
Cost of goods
$58.2m (FY, 2025)
Cost of goods
kr2.5m (FY, 2025)
Gross profit
Gross profit
$170.2m (FY, 2025)
Gross profit
kr72m (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Oncopeptides
HQ
Stockholm, SE
Employees
80

Oncopeptides is a clinical development pharmaceutical company.

View company